Artificial Intelligence
Aim of the [Merck-Afrigen Biologics] collaboration is to develop mRNA platform technology, scale up and troubleshoot challenges in mRNA process optimization Merck, a leading science and technology company, announced that its Life Science...
Published in bioRxiv, the study leverages Pangea Biomed’s ENLIGHT platform to develop a novel approach to precision cancer care that combines AI techniques and digital pathology, bypassing the need for expensive and time-consuming DNA and RNA...
Albuquerque, NM – 2 July 2024 – Indica Labs today announces the expansion of their reseller network in the Asia Pacific (APAC) region. New distributorship agreements have been inked with MRL Cybertec Corporation, Pathology Ware...
From the Paige blog: By now, AI’s ability to enhance diagnostic efficiency and reduce cancer detection errors is well documented, delivering benefits to pathologists and patients globally. Still, these outcomes are only the beginning of...
The World Health Organization (WHO) has awarded the Roche human papillomavirus (HPV) test prequalification designations for use on the cobas 5800 System and for self-collected samples on the cobas 5800, 6800 and 8800 Systems. These...
Proscia: Expanding Proscia’s precision medicine AI pipeline will help to optimize clinical trials and improve treatment decisions PHILADELPHIA and CHICAGO – JUNE 25, 2024 – Proscia®, a global leader in AI-enabled pathology solutions...
